Cyclic peptide LHRH antagonists
US5508383A · kind A · utility
5Cited by
2References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 9, 1994 |
| Grant date | Apr 16, 1996 |
| Priority date | — |
| Expiry date | Mar 9, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A class of cyclic peptides are effective inhibitors of LHRH and are useful in the treatment of disease conditions which are mediated by sex hormones including prostate cancer, endometriosis, uterine fibroids, and precocious puberty.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.